Gonadotrophin–releasing hormone administered in continuous low dose can induce ovulation and normal corpora lutea in acyclic post–partum ewes and seasonally anoestrous ewes

1994 ◽  
Vol 71 (4) ◽  
pp. 123-125 ◽  
Author(s):  
PJ WRIGHT ◽  
AH WILLIAMS ◽  
IJ CLARKE
2020 ◽  
Vol 32 (2) ◽  
pp. 206
Author(s):  
E. Rojas Canadas ◽  
S. E. Battista ◽  
J. Kieffer ◽  
S. Wellert ◽  
A. Garcia Guerra

Heifers typically have a reduced ovulation rate following gonadotrophin-releasing hormone (GnRH) application at initiation of a CO-Synch + controlled internal drug release (CIDR) protocol. Thus, the objective of the present study was to determine whether increasing the dose of GnRH at initiation of a 5-day CO-Synch protocol in beef heifers would improve ovulation rate and therefore increase pregnancies per AI (P/AI). Angus yearling heifers (n=299) at five locations in Ohio (United States) were randomised to receive either 100µg (single; n=149) or 200µg (double; n=150) of gonadorelin acetate (Gonabreed, Parnell) at initiation of a 5-day CO-Synch. On Day −8, heifers received a new intravaginal progesterone-releasing device (1.38g of progesterone; CIDR, Zoetis) and either a single or double dose of GnRH as described above. Five days later (Day −3), devices were removed, 1000µg of cloprostenol sodium (Estroplan, Parnell) was administered, and an oestrous detection patch was applied (Estrotect, Rockway Inc.). Sixty hours after device removal, AI was performed concurrently with the administration of 100µg of GnRH. Pregnancy was determined using ultrasonography 35 days after AI. Ovaries from a subset of animals (n=178) were examined on Days −8 and −3 using ultrasonography to determine the presence of corpora lutea (CL) and the size of the largest follicle. Data were analysed using the GLIMMIX procedure of SAS ver. 9.4 (SAS Institute Inc.). Oestrous expression was similar (P=0.50) between heifers treated with a single (49.0%) or double (52.7%) dose of GnRH. Overall, P/AI was similar (P=0.35) between heifers receiving a single (43.6%; 65/149) or double (38.7%; 58/150) dose of GnRH at initiation of the protocol. However, increasing the dose of GnRH resulted in a greater (P=0.04) ovulation rate in heifers in the double-dose group (40.9%; 36/88) compared with those in the single-dose group (26.1%; 23/88). In addition, heifers with a CL at the time of treatment had reduced ovulatory response to GnRH treatment (16.0%) compared with heifers without a CL (53.7%; P=0.001); however, there was no treatment×CL presence interaction (P=0.69). Heifers that did not ovulate to the initial GnRH treatment had a greater (P=0.0008) diameter of the largest follicle on Day −3 compared with heifers that did ovulate (11.4±0.2 vs. 10.0±0.3). Furthermore, heifers that did ovulate after the initial GnRH had greater (P=0.04) P/AI (52.5%) than heifers that did not ovulate (40.2%), and heifers with a CL on Day −8 tended (P=0.07) to have greater P/AI (47.9%) than heifers without a CL (40.2%). In addition, heifers with a CL present on Day −3 had greater (P=0.04) P/AI (48.2%) than heifers without a CL (31.7%). In summary, increasing the dose of GnRH at initiation of a 5-day CO-Synch did not affect fertility to fixed-time AI but enhanced ovulation rate in beef heifers. Furthermore, heifers that did ovulate at initiation of the protocol or that had a CL at device insertion or removal had greater fertility to fixed-time AI. Thus, alternative strategies that maximise ovulation at initiation of the synchronisation protocol are needed.


2021 ◽  
Vol 33 (2) ◽  
pp. 149
Author(s):  
N. E. S. Pereira ◽  
L. P. Martins ◽  
R. M. Moura ◽  
L. R. O. Dias ◽  
M. A. S. Peixer ◽  
...  

In the present study, we evaluated the ovarian response to exogenous FSH stimulation in the absence of endogenous LH, using as experimental model heifers immunized against GnRH. Pubertal, cycling Nelore (Bos indicus) heifers were allocated into three experimental groups: (1) non-immunized, FSH stimulated (B−FSH+, n=5), (2) immunized, FSH stimulated (B+FSH+, n=5), and (3) immunized, nonstimulated (B+FSH−, n=5). Active immunization was obtained by 3 subcutaneous injections of 1.0mL anti-gonadotrophin-releasing hormone vaccine (Bopriva, Zoetis), given at 20-day intervals. Effective immunization was characterised by the absence of growing follicles >4mm or corpora lutea (CL) on the ovaries. Follicular wave emergence was synchronized in groups B+FSH+ and B+FSH− by follicle ablation, and in group B−FSH+ by using of a protocol consisting of an injection of 2mg of oestradiol benzoate and 0.5mg of sodium cloprostenol, and insertion of an intravaginal progesterone (P4) device (1g). Four days later (Day 0), groups B−FSH+ and B+FSH+ received 100mg of NIH-FSH-P1 (Folltropin-V, Vetoquinol), injected twice-a-day in 8 decreasing doses, and group B+FSH− received saline. Transvaginal ultrasonography (7.5MHz) was performed daily from Days 0 to 4 and the number and size of follicles were recorded. P4 devices of group B-FSH+ were removed at Day 3. All heifers underwent ovum pickup (OPU) at Day 4, and the cumulus–oocyte complexes (COC) recovered were graded for quality. Viable COC were used for invitro embryo production. The heifers were re-evaluated at Day 11 (7 days after OPU). The GLIMMIX procedure from SAS (SAS Institute Inc.) with repeated-measure statement was used to analyse the effects of group, day, and interactions; and the Chi-squared method was used to analyse binomial data. The results are shown as mean±s.e.m. A progressive increase in average follicle size was observed in groups B−FSH+ and B+FSH+ (P<0.0001), whereas no follicle growth was observed in group B+FSH− (P>0.05). Follicle growth rate was similar between groups B−FSH+ and B+FSH+, and both were greater than group B+FSH− (1.2±0.2 and 1.1±0.1 vs. 0.0±0.1 mm/d; P<0.0001). However, the smaller follicle size in group B+FSH+ at Day 0 resulted in smaller follicle size at Day 4, compared with group B−FSH+ (2.4±0.1 vs. 3.6±0.2 and 6.9±0.7 vs. 8.2±0.6mm, respectively; P<0.05). There was no (P>0.05) difference in the number of COC recovered among groups. The group B+FSH+ yielded fewer (P<0.01) COC of grades I and II and more (P<0.01) degenerated oocytes than groups B−FSH+ and B+FSH− (41.2% vs. 80.0% and 68.0%, and 34.0% vs. 19.8 and 7.0%, respectively). Nevertheless, blastocyst rates were similar (P>0.05) for B−FSH+, B+FSH+, and B+FSH− (57.1%, 45.9% and 44.2%, respectively). Residual follicles or luteal tissue were observed after OPU only in group B−FSH+, resulting in a significant difference in the size of ovaries between Days 0 and 11, compared with that of groups B+FSH+ and B+FSH− (3.7±1.4 vs. 0.2±0.2 and −0.2±0.2cm2, respectively; P<0.05). In summary, exogenous FSH supported follicle growth but did not improve oocyte quality in heifers immunized against GnRH. This research was funded by CAPES.


1990 ◽  
Vol 126 (2) ◽  
pp. 297-307 ◽  
Author(s):  
H. M. Picton ◽  
C. G. Tsonis ◽  
A. S. McNeilly

ABSTRACT The study investigated the relationship between the plasma concentration of FSH and the stimulation of preovulatory follicle growth in vivo in ewes chronically treated with the gonadotrophin-releasing hormone (GnRH) agonist buserelin (HOE 766). Welsh Mountain ewes with regular oestrous cycles were treated for 6 weeks with two discs implants placed s.c., each containing 5 mg of the agonist in a matrix of polyhydroxybutyric acid. Treatment with the agonist for 35 days produced a sustained suppression of the plasma concentration of FSH, stopped the pulsatile release of LH and prevented follicular development beyond 2·5 mm diameter. There was no difference between the total number of follicles > 1·0 mm diameter present in the ovaries of GnRH agonist-treated ewes and day 8 luteal phase control ewes. During the sixth week of agonist treatment ewes were infused with ovine FSH (6 μg NIADDK-oFSH16/h) in the presence of only basal concentrations of LH. After 24, 48, 72 or 120 h of FSH infusion, the mean number of follicles > 1 ·0 mm diameter per ewe was not significantly different between treated and control animals. Infusion of FSH caused a timedependent increase in (1) the number of follicles per ovary >2·5 mm, (2) the mean diameter of these follicles and (3) the proportion of the large follicles which could be classified as oestrogenic (> 3·7 nmol oestradiol/follicle per h in vitro). Injection of human chorionic gonadotrophin (750IU i.m.) after 120 h of FSH infusion caused the majority of these large follicles to ovulate and form apparently normal corpora lutea. These results indicate that, in the absence of pulsatile LH, FSH stimulates the growth of normal large oestrogenic follicles which, when stimulated, ovulate to produce viable corpora lutea. Journal of Endocrinology (1990) 126, 297–307


Sign in / Sign up

Export Citation Format

Share Document